Q&A: Jonathan Kahn on New Frontiers in Racial Profiling
By Jonathan Moens,
Undark
| 12. 14. 2022
In October of this year, police officials in Edmonton, Canada were struggling to solve a 2019 sexual assault case in which a woman was left unconscious and almost fully unclothed in minus 16-degree Fahrenheit weather. There were no witnesses, no CCTV footage, nor any DNA matches in criminal databases, and the assailant was wearing heavy winter clothing, meaning the victim could only provide a vague description. Desperate for a break, the local police department resorted to a controversial technology for the first time in its history: forensic DNA phenotyping, which predicts a suspect’s physical features directly from their DNA.
The police posted a computer-generated mugshot of a young Black male of primarily East African ancestry. But just two days later, they removed it after the image was criticized on social media and in Edmonton’s Black community for its “broadness” and exacerbating racial stereotypes relating to criminal behavior. In the U.S., African Americans are about 7 times more likely to be wrongfully convicted of murder than White people. Black men are also about 2.5 times more likely than White men to...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...